Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

33

Revenue 2017

Humalog

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humalog was produced by Lilly.

Lilly joins new Medicare scheme to reduce insulin prices

Lilly joins new Medicare scheme to reduce insulin prices

Lilly has faced particularly strong criticism, after its widely-used Humalog insulin rose from $34 to $234 per vial between 2001 and 2015.

Lilly will aim for one $1bn-$5bn deal per quarter in 2020

Lilly will aim for one $1bn-$5bn deal per quarter in 2020 Lilly needs to refresh its pipeline as it continues to suffer from a decline across its older, established brands – including in its diabetes franchise, where its Humalog insulin is facing generic ... The company recently announced its will launch lower

Lilly extends range of cut-price insulins in the US

Lilly extends range of cut-price insulins in the US Cheaper, authorised generic versions of Lilly’s Humalog Junior KwikPen and Humalog Mix75/25 products – priced at $265.20 for a pack of five which is another 50% reduction on the ... Humalog pay less than $100 for their monthly prescription at retail

Novo follows Sanofi, Lilly with insulin price cut in US

Novo follows Sanofi, Lilly with insulin price cut in US which offered a 50% cheaper version of its Humalog (insulin lispro) the following month.

The fight for affordable insulin

The fight for affordable insulin The price of Humalog, more commonly used by type 1 patients, also saw its price rise 585% from $35 to $234 between 2001 and 2015. ... Lilly’s authorised generic. One company, Eli Lilly, has responded to the pleas for more affordable insulins, and

1 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics